These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21173410)

  • 1. ACP Journal Club. Population-based screening using prostate-specific antigen testing reduced prostate cancer mortality.
    Hoffman RM
    Ann Intern Med; 2010 Dec; 153(12):JC6-9. PubMed ID: 21173410
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. Periodic screening with prostate-specific antigen testing reduced mortality from prostate cancer.
    Canfield SE
    Ann Intern Med; 2009 Jun; 150(12):JC6-5, JC6-4. PubMed ID: 19528550
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club. Periodic PSA-based screening in men 55 to 69 years of age reduced prostate cancer mortality.
    Hoffman RM
    Ann Intern Med; 2012 Jul; 157(2):JC2-4. PubMed ID: 22801696
    [No Abstract]   [Full Text] [Related]  

  • 4. ACP Journal Club. Review: PSA-based screening does not reduce prostate cancer mortality or all-cause mortality.
    Dahm P
    Ann Intern Med; 2012 Apr; 156(8):JC4-02. PubMed ID: 22508742
    [No Abstract]   [Full Text] [Related]  

  • 5. ACP Journal Club. Annual screening for prostate cancer did not reduce mortality from prostate cancer.
    Canfield SE
    Ann Intern Med; 2009 Jun; 150(12):JC6-4, JC6-5. PubMed ID: 19528549
    [No Abstract]   [Full Text] [Related]  

  • 6. ACP Journal Club. Review: Prostate cancer screening using PSA does not decrease mortality.
    Luckmann R
    Ann Intern Med; 2011 Jan; 154(2):JC1-2. PubMed ID: 21242356
    [No Abstract]   [Full Text] [Related]  

  • 7. ACP Journal Club. Radiation plus androgen deprivation therapy reduced mortality in locally advanced prostate cancer.
    Canfield SE; Dahm P
    Ann Intern Med; 2012 Apr; 156(8):JC4-05, JC4-04. PubMed ID: 22508745
    [No Abstract]   [Full Text] [Related]  

  • 8. ACP Journal Club. Radical prostatectomy reduced mortality and disease progression over the long term more than watchful waiting in early prostate cancer.
    Canfield SE
    Ann Intern Med; 2011 Jul; 155(2):JC1-2. PubMed ID: 21768568
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.
    Colli JL; Amling CL
    Prostate Cancer Prostatic Dis; 2008; 11(3):247-51. PubMed ID: 18268527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACP Journal Club. Radical prostatectomy and observation did not differ for mortality in localized prostate cancer.
    Dahm P; Gilbert S
    Ann Intern Med; 2012 Oct; 157(8):JC4-5. PubMed ID: 23070507
    [No Abstract]   [Full Text] [Related]  

  • 12. ACP Journal Club. Review: Androgen deprivation therapy does not increase CV mortality in prostate cancer.
    Canfield SE; Dahm P
    Ann Intern Med; 2012 Apr; 156(8):JC4-04, JC4-05. PubMed ID: 22508744
    [No Abstract]   [Full Text] [Related]  

  • 13. ACP Journal Club. Once-only flexible sigmoidoscopy screening reduced colorectal cancer incidence and mortality.
    Koretz RL
    Ann Intern Med; 2010 Oct; 153(8):JC4-4. PubMed ID: 20956700
    [No Abstract]   [Full Text] [Related]  

  • 14. ACP Journal Club. Flexible sigmoidoscopy screening reduced colorectal cancer incidence and mortality in older adults.
    Kahi CJ; Imperiale TF
    Ann Intern Med; 2012 Sep; 157(6):JC3-3. PubMed ID: 22986395
    [No Abstract]   [Full Text] [Related]  

  • 15. ACP Journal Club. Intermittent and continuous androgen deprivation did not differ for mortality after radiotherapy for prostate cancer.
    Stockler MR
    Ann Intern Med; 2013 Jan; 158(2):JC9. PubMed ID: 23318343
    [No Abstract]   [Full Text] [Related]  

  • 16. ACP Journal Club. Review: CT screening for lung cancer reduced mortality in 1 large trial but not in 2 smaller trials.
    Neugut AI; Accordino MK
    Ann Intern Med; 2012 Sep; 157(6):JC3-6. PubMed ID: 22986398
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control study.
    Kopec JA; Goel V; Bunting PS; Neuman J; Sayre EC; Warde P; Levers P; Fleshner N
    J Urol; 2005 Aug; 174(2):495-9; discussion 499. PubMed ID: 16006879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States.
    Shaw PA; Etzioni R; Zeliadt SB; Mariotto A; Karnofski K; Penson DF; Weiss NS; Feuer EJ
    Am J Epidemiol; 2004 Dec; 160(11):1059-69. PubMed ID: 15561985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit.
    van Leeuwen PJ; Connolly D; Gavin A; Roobol MJ; Black A; Bangma CH; Schröder FH
    Eur J Cancer; 2010 Jan; 46(2):377-83. PubMed ID: 19804966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rural residence and prostate cancer screening with prostate-specific antigen.
    Stamatiou K; Skolarikos A
    Rural Remote Health; 2009; 9(2):1227. PubMed ID: 19594290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.